DYNAGLIPT LM 2.5/500 (Metformin (500mg) + Linagliptin (2.5mg))

Dynaglipt LM 500mg/2.5mg Tablet is a medicinal product that combines two active ingredients designed to assist in managing elevated blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This medication enhances the effectiveness of insulin and decreases the quantity of glucose generated by the liver. It may be prescribed as a standalone treatment or alongside other anti-diabetic drugs. For optimal results, it is recommended to adhere to a balanced diet and incorporate physical activity into your routine. The dosage is tailored to the individual’s specific medical condition, current blood sugar readings, and any other medications being taken concurrently. Consuming this tablet with meals may help alleviate gastrointestinal discomfort. It is crucial to use Dynaglipt LM 500mg/2.5mg Tablet strictly according to your physician’s instructions. To achieve the best outcomes, follow the prescribed treatment plan diligently without making unauthorized changes to your dose or discontinuing use without prior consultation with your healthcare provider. Maintaining a healthy lifestyle plays a vital role in diabetes management. Possible adverse effects associated with this medication include headaches, nausea, dizziness, and skin rashes. Users should also watch for symptoms of low blood sugar (hypoglycemia), particularly if this medication is used with other treatments such as insulin or sulfonylureas. If side effects persist or worsen, seek medical advice. Disclose any history of kidney, liver, heart disease, or pancreatic conditions to your doctor before starting this medication. Pregnant or breastfeeding individuals should seek medical guidance before use. It is important to inform your healthcare provider of all medications you are currently taking to avoid potential interactions. Alcohol consumption should be avoided as it can lower blood sugar levels. Regular monitoring of kidney function and blood glucose levels will occur throughout treatment. Notably, this medication is not indicated for the treatment of type 1 diabetes.